Two Sigma Securities »

Pharmacyte Biotech shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $54k 28k 1.96

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Pharmacyte Biotech

K2 Principal Fund
Geode Capital Management
Equitec Proprietary Markets
Renaissance Technologies
Susquehanna International
Dimensional Fund Advisors
Schonfeld Strategic Advisors
Northern Trust
Acadian Asset Management
Aspire Private Capital
Advisor Group Holdings
Covestor
Bank of America Corporation
Royal Bank of Canada
Planning Capital Management Corp

View all funds holding Pharmacyte Biotech